Sign In
Buy NVCR
$16.15
+0.330 (+2.09%)
At Close: Jun 03, 2026
Oncology Space Gains Momentum in 2021: 5 Stocks to Focus on
09:01am, Friday, 02'nd Jul 2021
Oncology stocks like OncoCyte (OCX), PerkinElmer (PKI), Catalent (CTLT), Cardiff Oncology (CRDF) and NovoCure (NVCR) are expected to continue their run over the next few months.
Why Did Novocure Shares Plunge Today?
02:53pm, Thursday, 01'st Jul 2021
Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer AG's (OTC: BAYRY) Nexavar (sorafenib)
NVCR Stock Price Falls Over 15%: Why It Happened
01:58pm, Thursday, 01'st Jul 2021
The stock price of Novocure Ltd (NASDAQ: NVCR) fell by over 15% during intraday trading. This is why it happened.
Why Novocure Stock Is Sliding Today
11:21am, Thursday, 01'st Jul 2021
Investors hoped for better results from the company's phase 2 study.
Novocure Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver Cancer
07:15am, Thursday, 01'st Jul 2021
ST. HELIER, Jersey--(BUSINESS WIRE)-- #patientforward--Novocure announced final safety and efficacy results from its HEPANOVA trial in liver cancer, and plans to proceed with a phase 3 pivotal trial.
Up 1,100%, This Cancer-Fighting Stock Has Room To Run
11:02am, Tuesday, 29'th Jun 2021
NovoCure's unique treatment for cancerous tumors is both a medical breakthrough and an investment opportunity.
4 Toxic Stocks That May Disrupt Your Peace & Portfolio
09:54am, Tuesday, 29'th Jun 2021
Investors who can pinpoint the overhyped toxic stocks and discard them at the right time are the ones who are poised to benefit.
Novocure Initiates Usability Study for Flexible Torso Array
07:30am, Wednesday, 16'th Jun 2021
ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure announced it has advanced a new, flexible torso array into a clinical usability study.
NovoCure: The Future Of Cancer Treatment
03:59pm, Saturday, 12'th Jun 2021
As it harnesses the power of an electromagnetic field, NovoCure offers hope to countless patients suffering from aggressive cancers. Tumor Treating Fields are now approved for deadly cancers, includin
Could Novocure Be a Millionaire-Maker Stock?
10:12am, Wednesday, 12'th May 2021
It's a good stock, but it might struggle to make you rich overnight.
Is Novocure Stock Overvalued?
07:11am, Friday, 30'th Apr 2021
Did the market overreact to the company's good news?
Recap: NovoCure Q1 Earnings
07:20am, Thursday, 29'th Apr 2021
Shares of NovoCure (NASDAQ:NVCR) fell 2.7% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 200.00% year over year to ($0.04), which missed t
Why NovoCure (NVCR) Might Surprise This Earnings Season
10:02am, Wednesday, 28'th Apr 2021
NovoCure (NVCR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
NovoCure (NVCR) is Overbought: Is A Drop Coming?
09:01am, Monday, 26'th Apr 2021
NovoCure Limited (NVCR) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
Stock Market Slumps On Biden Capital Gains Tax Plan; Novocure Strong, HubSpot, Marriott Set Up
04:19pm, Thursday, 22'nd Apr 2021
Stock market slumps on Biden capital gains tax plan; Novocure strong, HubSpot, Marriott set up. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock li
